DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vanos (Fluocinonide Topical) - News

 
 



News related to Vanos (Fluocinonide Topical) and/or conditions it is approved for

Sex Life Suffers with Psoriasis 'Down There'
Source: MedPage Today Dermatology [2015.04.09]
(MedPage Today) -- Quality of life takes a hit from genital involvement.

Ingredient in MS, Psoriasis Drugs Linked to Two Deadly Brain Infections
Source: MedicineNet Psoriasis Specialty [2015.04.09]
Title: Ingredient in MS, Psoriasis Drugs Linked to Two Deadly Brain Infections
Category: Health News
Created: 4/8/2015 12:00:00 AM
Last Editorial Review: 4/9/2015 12:00:00 AM

Psoriasis
Source: MedicineNet Actinic Keratosis Specialty [2015.03.31]
Title: Psoriasis
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/31/2015 12:00:00 AM

Boehringer Ingelheim's investigational biologic cleared skin better than ustekinumab in head-to-head Phase II psoriasis study
Source: Dermatology News From Medical News Today [2015.03.25]
For the first time, Boehringer Ingelheim announced Phase II data from its investigational compound BI 655066*.

Tough-to-Treat Psoriasis Responds to Anti-PDE4
Source: MedPage Today Allergy & Immunology [2015.03.25]
(MedPage Today) -- Response at 16 weeks maintained a full year in most cases.

Oral Otezla (apremilast) long-term safety and efficacy data in patients with moderate to severe plaque psoriasis presented
Source: Arthritis / Rheumatology News From Medical News Today [2015.03.24]
Celgene Corporation has announced that results from long-term efficacy and safety analyses of the ESTEEM phase III clinical trial program of Otezla® (apremilast) were presented at the 73rd...

Results from Phase III study evaluating oral otezla or injectable etanercept versus placebo in patients with moderate to severe plaque psoriasis
Source: Dermatology News From Medical News Today [2015.03.24]
Celgene Corporation has announced that results from its ongoing phase III LIBERATE trial evaluating Otezla® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4)...

Psoriasis Pictures Slideshow: See Moderate to Severe Forms of this Common Skin Condition
Source: MedicineNet Actinic Keratosis Specialty [2015.01.15]
Title: Psoriasis Pictures Slideshow: See Moderate to Severe Forms of this Common Skin Condition
Category: Slideshows
Created: 2/3/2015 12:00:00 AM
Last Editorial Review: 1/15/2015 12:00:00 AM

Scalp Psoriasis
Source: MedicineNet alefacept Specialty [2014.05.20]
Title: Scalp Psoriasis
Category: Diseases and Conditions
Created: 7/24/2012 3:21:00 PM
Last Editorial Review: 5/20/2014 12:00:00 AM

Psoriasis Drug May Help Treat Type 1 Diabetes: Report
Source: MedicineNet alefacept Specialty [2013.09.24]
Title: Psoriasis Drug May Help Treat Type 1 Diabetes: Report
Category: Health News
Created: 9/23/2013 7:35:00 PM
Last Editorial Review: 9/24/2013 12:00:00 AM

Psoriasis Quiz: Test Your Medical IQ
Source: MedicineNet alefacept Specialty [2011.08.16]
Title: Psoriasis Quiz: Test Your Medical IQ
Category: MedicineNet Quiz
Created: 4/21/2011 3:23:00 PM
Last Editorial Review: 8/16/2011 1:27:34 PM

Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.

Remsima (infliximab) accepted for restricted use in NHS Scotland by the Scottish Medicines Consortium
Source: Arthritis / Rheumatology News From Medical News Today [2015.03.11]
Patients in Scotland suffering from inflammatory conditions including rheumatoid arthritis (RA), Crohn's Disease (CD), ulcerative colitis (UC), and psoriasis will now have access to a new wave of...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015